Vote Scores
Filings read through

Bio-Rad Laboratories, Inc.: how funds voted at the meeting of 21 Apr 2026

Ticker
BIO
Meeting
Season
year to 30 June 2026
Filers reporting
594
Ballot items
5

594 filers on Form N-PX reported votes at the Bio-Rad Laboratories, Inc. meeting of 21 Apr 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 73.0% of the reported votes are for. 56 filers withheld from or voted against at least one nominee.

    784 vote records from 182 filers. 42 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 35
    • Against 9
    • Against management 9
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    920 vote records from 589 filers. 54 of the 562 filers that marked the item voted against management. 27 filers gave no management mark.

    • Positions of 48 fund families
    • For 43
    • Against 5
    • Against management 5
  3. Item 3: Audit-related items (auditor ratification)

    391 vote records from 182 filers. 2 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    418 vote records from 188 filers. 2 of the 185 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
  5. Item 5: Stockholder proposal regarding dual class capital structure.

    388 vote records from 179 filers. 165 of the 177 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
    • Against management 43

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Bio-Rad Laboratories, Inc., meeting of 21 Apr 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor5. Proposal
AllianceBernsteinForNo reportNo report
AllspringForForFor, against management
American CenturyForForFor, against management
BairdForNo reportNo report
BlackRock and iSharesForForFor, against management
BNY MellonAgainst, against managementForFor, against management
Brighthouse FundsForForFor, against management
Capital Group and American FundsAgainst, against managementForFor, against management
Charles SchwabForForFor, against management
Columbia ThreadneedleForForFor, against management
DimensionalForForFor, against management
DWSForNo reportNo report
EquitableForForFor, against management
Federated HermesForForFor, against management
FidelityForForFor, against management
First TrustForForFor
Franklin TempletonForForFor, against management
Goldman SachsForForFor, against management
Guggenheim and RydexForForFor, against management
Harbor FundsForForFor, against management
InvescoAgainst, against managementForFor, against management
J.P. MorganForForFor, against management
Jackson National fundsAgainst, against managementForFor, against management
John Hancock and ManulifeForForFor, against management
Lincoln FinancialForForFor, against management
MassMutualForForFor, against management
MFSForForFor, against management
Morgan Stanley, Eaton Vance and CalvertForForFor, against management
NationwideForForFor, against management
Natixis and Loomis SaylesForForFor, against management
Neuberger BermanForNo reportNo report
Northern Trust and FlexSharesForForFor, against management
Nuveen and TIAAForForFor, against management
Pacific Life fundsForForFor, against management
PGIM and PrudentialForForFor, against management
PIMCOForForFor, against management
PrincipalForForFor, against management
ProShares and ProFundsForForFor, against management
Russell InvestmentsForForFor, against management
SEIForForFor, against management
State Street and SPDRForForFor, against management
T. Rowe PriceForForFor, against management
ThriventForForFor, against management
TransamericaForForFor, against management
VanguardForForFor, against management
Victory CapitalForForFor, against management
VoyaForForFor, against management
WisdomTreeAgainst, against managementForFor, against management

Questions

How many filers reported votes at the Bio-Rad Laboratories, Inc. meeting?
594 Form N-PX filers reported votes at the meeting of 21 Apr 2026. On say-on-pay, 54 of 562 filers that marked the item voted against management (9.6%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Bio-Rad Laboratories, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Bio-Rad Laboratories, Inc. with a meeting date within three days of 21 Apr 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .